CTNS and COVID-19: The dose–response analysis showed that for every 1 × 99th percentile URL increment in cTns elevation, the pooled OR was 1.23(95% CI 1.20–1.26, P = 0.000) for the risk of short-term all-cause mortality in patients with COVID-19 (Supplementary Figure 2).